In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
IGM Biosciences Inc (NASDAQ: IGMS) closed the day trading at $1.77 down -3.28% from the previous closing price of $1.83. In other words, the price has decreased by -$3.28 from its previous closing price. On the day, 0.32 million shares were traded. IGMS stock price reached its highest trading level at $1.91 during the session, while it also had its lowest trading level at $1.755.
Ratios:
For a better understanding of IGMS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.22 and its Current Ratio is at 5.22. In the meantime, Its Debt-to-Equity ratio is 0.58 whereas as Long-Term Debt/Eq ratio is at 0.50.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on January 10, 2025, Downgraded its rating to Hold and sets its target price to $2.50 from $27 previously.
On January 10, 2025, RBC Capital Mkts Downgraded its rating to Sector Perform which previously was Outperform and also lowered its target price recommendation from $20 to $1.50.
Morgan Stanley Downgraded its Equal-Weight to Underweight on January 10, 2025, whereas the target price for the stock was revised from $12 to $2.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 15 ’25 when Weber Steven sold 1,122 shares for $1.70 per share. The transaction valued at 1,907 led to the insider holds 30,582 shares of the business.
Weber Steven sold 539 shares of IGMS for $4,032 on Dec 16 ’24. The PRINCIPAL ACCOUNTING OFFICER now owns 31,704 shares after completing the transaction at $7.48 per share. On Dec 16 ’24, another insider, Decker Lisa Lynn, who serves as the CHIEF BUSINESS OFFICER of the company, sold 1,063 shares for $7.48 each. As a result, the insider received 7,951 and left with 78,041 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IGMS now has a Market Capitalization of 105251632 and an Enterprise Value of -67678400. For the stock, the TTM Price-to-Sale (P/S) ratio is 36.04 while its Price-to-Book (P/B) ratio in mrq is 1.33. Its current Enterprise Value per Revenue stands at -23.193 whereas that against EBITDA is 0.302.
Stock Price History:
The Beta on a monthly basis for IGMS is 0.10, which has changed by -0.8401084 over the last 52 weeks, in comparison to a change of 0.23631513 over the same period for the S&P500. Over the past 52 weeks, IGMS has reached a high of $22.50, while it has fallen to a 52-week low of $1.59. The 50-Day Moving Average of the stock is -78.48%, while the 200-Day Moving Average is calculated to be -82.52%.
Shares Statistics:
Over the past 3-months, IGMS traded about 406.11K shares per day on average, while over the past 10 days, IGMS traded about 1300890 shares per day. A total of 34.06M shares are outstanding, with a floating share count of 17.58M. Insiders hold about 70.43% of the company’s shares, while institutions hold 30.68% stake in the company. Shares short for IGMS as of 1735603200 were 2511803 with a Short Ratio of 6.18, compared to 1732838400 on 2703497. Therefore, it implies a Short% of Shares Outstanding of 2511803 and a Short% of Float of 16.510001.
